pharma news today obesity drugs glp-1 september 2025 Drugs, Digital Health & Trends in 2026 Swiss Re says GLP-1 drugs
Description
Importantly, visualizing gastric contents with ultrasound can facilitate clearer communication with patients and surgeonsoften leading to greater understanding and acceptance of clinical decisions compared to relying solely on guideline-based explanations
Germany, the UK, France, and Scandinavia are the primary European GLP-1 markets, with strong diabetes prescribing supported by national guideline recommendations and health insurance coverage
Publications address the pharmacokinetic challenges of oral peptide delivery, real-world effectiveness of approved oral formulations, and emerging technologies for non-injectable administration [11, 12, 35]
During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, et al
Matching your injection day to your lifestyle The best injection day is the one that creates the least disruption and the most benefit
